We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ACET market cap is 80.74M. The company's latest EPS is USD -1.7313 and P/E is -1.32.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -52.26M | -31.57M | -30.87M | -32.85M | -33.15M |
| Net Income | -49.89M | -29.49M | -28.02M | -29.9M | -30.48M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 17.9M | 9.73M | 24.99M | 0 |
| Operating Income | -85.46M | -39.19M | -62.04M | -72.55M | -152.04M |
| Net Income | -82.74M | -36.68M | -62M | -69.79M | -142.66M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 233.26M | 207.3M | 293.1M | 268.84M | 245.96M |
| Total Liabilities | 38.58M | 37.12M | 34.29M | 33.73M | 34.43M |
| Total Equity | 194.68M | 170.18M | 258.8M | 235.11M | 211.53M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 93.91M | 153.84M | 338.94M | 330.69M | 207.3M |
| Total Liabilities | 12.21M | 44.01M | 35.81M | 38.35M | 37.12M |
| Total Equity | 81.7M | 109.83M | 303.13M | 292.34M | 170.18M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -70.23M | -93.72M | -22.85M | -46.27M | -68.28M |
| Investing | -4.33M | -4.46M | -239k | -541k | -97.12M |
| Financing | 160k | 236k | 110.97M | 111.17M | 111.17M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -73.68M | -43.85M | -51.05M | -44.77M | -93.72M |
| Investing | 44.13M | 115.22M | -2.8M | -16.78M | -4.46M |
| Financing | 56.45M | 303k | 242.69M | 41.51M | 236k |
| Market Cap | 80.74M |
| Price to Earnings Ratio | -1.32 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.18 |
| Price to Book Ratio | 1.1 |
| Dividend Yield | - |
| Shares Outstanding | 82.4M |
| Average Volume (1 week) | 384.02k |
| Average Volume (1 Month) | 1.64M |
| 52 Week Change | -62.46% |
| 52 Week High | 2.61 |
| 52 Week Low | 0.81 |
| Spread (Intraday) | 0.02 (1.56%) |
| Company Name | Adicet Bio Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.adicetbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
